Abstract
Autism is a pervasive developmental disorder, defined by impairments in social and communication function and repetitive and stereotyped behavioral patterns. It occurs in approximately 7–40 out of 10,000 persons. Autism spectrum disorders (ASDs) represent a heterogeneous group of neurodevelopmental disorders, including autism, Asperger syndrome, childhood disintegrative disorder, and pervasive developmental disorder not otherwise specified, and are characterized by social and communication deficits accompanied by repetitive and stereotype behaviors, with onset before 3 years of age (American Psychiatric Association 2013; DiCicco-Bloom et al. 2006; Caglayan 2010). The prevalence of autism spectrum disorders is at least 5–6/1,000 and may be higher (Bryson and Smith 1998).
References
Agency for Healthcare Research and Quality. (2014). Therapies for children with autism spectrum disorder: Behavioral interventions update (AHRQ publication, Vol. 14-EF). Rockville: Agency for Healthcare Research and Quality.
American Psychiatric Association. (2013). Autism spectrum disorder. In Diagnostic and statistical manual of mental disorders (5th ed., p. 50). Arlington: American Psychiatric Association.
Anagnostou, E., Zwaigenbaum, L., Szatmari, P., et al. (2014). Autism spectrum disorder: Advances in evidence-based practice. Canadian Medical Association Journal, 186, 509–519.
Aneja, A., & Tierney, E. (2008). Autism: The role of cholesterol in treatment. International Review of Psychiatry, 20, 165–170.
Asperger, H. (1944). Autistic psychopathy in childhood. In U. Frith (Ed.), Autism and Asperger syndrome (trans & annotated: Frith, U., 1991). Cambridge, UK: Cambridge University Press.
Augustyn, M. (2014). Autism spectrum disorder: Diagnosis. UpToDate, 9 Sept 2014.
Baieli, S., Pavone, L., Meli, C., et al. (2003). Autism and phenylketonuria. Journal of Autism and Developmental Disorders, 33, 201–204.
Bailey, A., Phillips, W., & Rutter, M. (1996). Autism: Toward an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. Journal of Child Psychology and Psychiatry, 37, 89–126.
Baker, Z., & Jeste, S. S. (2015). Diagnosis and management of autism spectrum disorder in the era of genomics. Rare disorders can pave the way for targeted treatments. Pediatric Clinics of North America, 62, 607–618.
Battaglia, A. (2008). The inv dup (15) or idic (15) syndrome (tetrasomy 15q). Orphanet Journal of Rare Diseases, 19, 3.
Ben Shachar, S., Lanpher, B., German, J. R., et al. (2009). Microdeletion 15q13.3: A locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. Journal of Medical Genetics, 46, 382–388.
Bennetto, L., & Rogers, S. J. (2001). Autism spectrum disorders, Chapter 55. In J. L. Jacobson (Ed.), Psychiatric secrets (2nd ed., pp. 295–302). Philadelphia: Hanley and Belfus.
Bolton, P., Macdonald, H., Pickles, A., et al. (1994). A case–control family history study of autism. Journal of Child Psychology and Psychiatry, 35, 877–900.
Bryson, S., & Smith, I. (1998). Epidemiology of autism: Prevalence, associated characteristics, and implications for research and service delivery. Mental Retardation and Developmental Disabilities Research Reviews, 4, 97–103.
Butler, M. G., Dasouki, M. J., Zhou, X. P., et al. (2005). Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. Journal of Medical Genetics, 42, 318–321.
Buxbaum, J. D., Cai, G., Chaste, P., et al. (2007). Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144B, 484–891.
Caglayan, A. O. (2010). Genetic causes of syndromic and non-syndromic autism. Developmental Medicine and Child Neurology, 52, 130–138.
Carter, M. T., & Scherer, S. W. (2013). Autism spectrum disorder in the genetics clinic: A review. Clinical Genetics, 83, 399–407.
Christian, S. L., Brune, C. W., Sudi, J., et al. (2008). Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biological Psychiatry, 63, 1111–1117.
Cohen, D. J., & Volkmar, F. R. (Eds.). (1997). Handbook of autism and pervasive developmental disorders (2nd ed.). New York: Wiley.
Devlin, B., & Scherer, S. W. (2012). Genetic architecture in autism spectrum disorder. Current Opinion in Genetics & Development, 22, 229–237.
DiCicco-Bloom, E., Lord, C., Zwaigenbaum, L., et al. (2006). The developmental neurobiology of autism spectrum disorder. Journal of Neuroscience, 26, 6897–6906.
Dykens, E. M., Finucane, B. M., & Gayley, C. (1997). Brief report: Cognitive and behavioral profiles in persons with Smith-Magenis syndrome. Journal of Autism and Developmental Disorders, 27, 203–211.
Filipek, P. A., Accaardo, P. J., Ashwal, M. D., et al. (2000). Practice parameter: Screening and diagnosis of autism. Report of the quality standards subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology, 55, 468–479.
Frith, U. (1991). Autistic psychopathy in childhood. Autism and Asperger syndrome (pp. 37–92). Cambridge University Press, Cambridge, England.
Frith, U. (2004). Emanuel Miller lecture: Confusions and controversies about Asperger syndrome. Journal of Child Psychology and Psychiatry, 45, 672–686.
Gillberg, C. (1998). Chromosomal disorders and autism. Journal of Autism and Developmental Disorders, 28, 415–425.
Harrington, J. W., & Allen, H. (2014). The clinician’s guide to autism. Pediatrics in Review, 35, 62–78.
Heil, K. M., & Schaaf, C. P. (2013). The genetics of autism spectrum disorders – A guide for clinicians. Current Psychiatry Reports, 15, 334.
Hendriksen, J. G., & Vles, J. S. (2008). Neuropsychiatric disorders in males with Duchenne muscular dystrophy: Frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder. Journal of Child Neurology, 23, 477–481.
Herman, G. E., Butter, E., Enrile, B., et al. (2007). Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly. American Journal of Medical Genetics Part A, 143, 589–593.
Hess, K., Morrier, M., Heflin, L., et al. (2008). Autism treatment survey: Services received by children with autism spectrum disorders in public school classrooms. Journal of Autism and Developmental Disorders, 38, 961–971.
Jamain, S., Quach, H., Betancur, C., et al. (2003). Paris Autism Research International Sibpair Study. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature Genetics, 34, 27–29.
Ji, N. Y., & Findling, R. L. (2015). An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Current Opinion of Psychiatry, 28, 91–101.
Karpf, J., Turk, J., & Howlin, P. (2004). Cognitive, language, and adaptive behavior profiles in individuals with a diagnosis of Cohen syndrome. Clinical Genetics, 65, 327–332.
Kent, L., Evans, J., Paul, M., et al. (1999). Comorbidity of autistic spectrum disorders in children with down syndrome. Developmental Medicine and Child Neurology, 41, 152–158.
King, B. H., & Bostic, J. Q. (2006). An update on pharmacologic treatments for autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America, 15, 161–175.
Kumar, R. A., Karamohamed, S., Sudi, J., et al. (2008). Recurrent 16p11.2 microdeletions in autism. Human Molecular Genetics, 17, 628–638.
Lai, M.-C., Lombardo, M. B., & Baron-Cohen, S. (2014). Autism. Lancet, 383, 896–910.
Landa, R. J. (2008). Diagnosis of autism spectrum disorders in the first 3 years of life. Nature Clinical Practice Neurology, 4, 138–147.
Lauritsen, M. B., Pedersen, C. B., & Mortensen, P. B. (2005). Effects of familial risk factors and place of birth on the risk of autism: A nationwide register-based study. Journal of Child Psychology and Psychiatry, 46, 963–971.
Levy, S. E., Mandell, D. S., & Schultz, R. T. (2009). Autism. Lancet, 374, 1627–1638.
Lintas, C., & Persico, A. M. (2009). Autistic phenotypes and genetic testing: State-of-the-art for the clinical geneticist. Journal of Medical Genetics, 46, 1–8.
Malhotra, D., & Sebat, J. (2012). CNVs: Harbingers of a rare variant revolution in psychiatric genetics. Cell, 148, 1223–1241.
Marshall, C. R., Noor, A., Vincent, J. B., et al. (2008). Structural variation of chromosomes in autism spectrum disorder. American Journal of Human Genetics, 82, 477–488.
Miles, J. H. (2011). Autism spectrum disorders-A genetics review. Genetics in Medicine, 13, 278–294.
Miles, J. H., Takahashi, T. N., Bagby, S., et al. (2005). Essential versus complex autism: Definition of fundamental prognostic subtypes. American Journal of Medical Genetics Part A, 135, 171–180.
Miles, J. H., McCathren, R. B., Stichter, J., et al. (2010). Autism spectrum disorders. GeneReviews. Updated 13 Apr 2010. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1442/
Miller, D. T., Shen, Y., Weiss, L. A., et al. (2009). Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. Journal of Medical Genetics, 46, 242–248.
Moessner, R., Marshall, C. R., Sutcliffe, J. S., et al. (2007). Contribution of SHANK3 mutations to autism spectrum disorder. American Journal of Human Genetics, 81, 1289–1297.
Muhle, R., Trentacoste, S. V., & Rapin, I. (2004). The genetics of autism. Pediatrics, 113, e472–e486.
Myers, S. M. (2009). Management of autism spectrum disorders in primary care. Pediatric Annals, 38, 42–49.
Neale, B. M., Kou, Y., Liu, L., et al. (2012). Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature, 485, 242–245.
Neufeld, E. F., & Muenzer, J. (2001). The mucopolysaccharidoses. In C. R. Scriver, A. L. Beaudet, W. S. Sly, & D. Valle (Eds.), The metabolic and molecular bases of inherited disease (pp. 3421–3452). New York: McGraw-Hill.
Noor, A., Whibley, A., Marshall, C. R., et al. (2010). Disruption at the PTCHD1 Locus on Xp22.11 in autism spectrum disorder and intellectual disability. Science Translational Medicine, 2(49), 49ra68.
O’Roak, B. J., Vives, L., Girirajan, S., et al. (2012). Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature, 485, 246–250.
Oliveira, G., Diogo, L., Grazina, M., et al. (2005). Mitochondrial dysfunction in autism spectrum disorders: A population-based study. Developmental Medicine and Child Neurology, 47, 185–189.
Ospina, M. B., Krebs Seida, J., Clark, B., et al. (2008). Behavioural and developmental interventions for autism spectrum disorder: A clinical systematic review. PloS One, 3, e3755.
Pagnamenta, A. T., Wing, K., Akha, E. S., et al. (2009). A 15q13.3 microdeletion segregating with autism. European Journal of Human Genetics, 17, 687–692.
Paul, R. (2008). Interventions to improve communication in autism. Child and Adolescent Psychiatric Clinics of North America, 17, 835–856.
Pinto, D., Pagnamenta, A. T., Klei, L., et al. (2010). Functional impact of global rare copy number variation in autism spectrum disorders. Nature, 466, 368–372.
Pinto, D., Delaby, E., Merico, D., et al. (2014). Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. American Journal of Human Genetics, 94, 677–694.
Prater, C. D. (2002). Autism: A medical primer. American Family Physician, 66, 1667–1674.
Ritvo, E. R., Jorde, L. B., Mason-Brothers, A., et al. (1989). The UCLA-University of Utah epidemiologic survey of autism: Recurrence risk estimates and genetic counseling. American Journal of Psychiatry, 146, 1032.
Rogers, S. J., & Vismara, L. A. (2008). Evidence-based comprehensive treatments for early autism. Journal of Clinical Child and Adolescent Psychology, 37, 8–38.
Ronemus, M., Iossifov, Il, Levy, D., et al. (2014). The role of de novo mutations in the genetics of autism spectrum disorders. Nature Reviews. Genetics, 15, 133–141.
Sanders, S. J., Murtha, M. T., Gupta, A. R., et al. (2012). De novo mutations revealed by whole exome sequencing are strongly associated with autism. Nature, 485, 237–241.
Schaefer, G. B., & Mendelsohn, N. J. (2013). Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genetics in Medicine, 15, 399–407.
Schlosser, R. W., & Wendt, O. (2008). Effects of augmentative and alternative communication intervention on speech production in children with autism: A systematic review. American Journal of Speech-Language Pathology, 17, 212–230.
Sebat, J., Lakshmi, B., Malhotra, D., et al. (2007). Strong association of de novo copy number mutations with autism. Science, 316, 445–449.
Seida, J. K., Ospina, M. B., Karkhaneh, M., et al. (2009). Systematic reviews of psychosocial interventions for autism: An umbrella review. Developmental Medicine and Child Neurology, 51, 95–104.
Selkirk, C. G., McCarthy Veach, P., Lian, F., et al. (2009). Parents’ perceptions of autism spectrum disorder etiology and recurrence risk and effects of their perceptions on family planning: Recommendations for genetic counselors. Journal of Genetic Counseling, 18, 507–519.
Sikora, D. M., Pettit-Kekel, K., Penfield, J., et al. (2006). The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. American Journal of Medical Genetics Part A, 140, 1511–1518.
Spiegel, E. K., Colman, R. F., & Patterson, D. (2006). Adenylosuccinate lyase deficiency. Molecular Genetics and Metabolism, 89, 19–31.
Splawski, I., Timothy, K. W., Sharpe, L. M., et al. (2004). Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell, 119, 19–31.
Steiner, C. E., Guerreiro, M. M., & Marques-de-Faria, A. P. (2003). Genetic and neurological evaluation in a sample of individuals with pervasive developmental disorders. Arquivos de Neuro-Psiquiatria, 61, 176–180.
Wassink, T. H., Piven, J., & Patil, S. R. (2001). Chromosomal abnormalities in a clinic sample of individuals with autistic disorder. Psychiatric Genetics, 11, 57–63.
Weiss, L. A., Shen, Y., Korn, J. M., et al. (2008). Association between microdeletion and microduplication at 16p11.2 and autism. The New England Journal of Medicine, 358, 667–675.
Yu, T. W., Chahrour, M. H., Coulter, M. E., et al. (2013). Using whole-exome sequencing to identify inherited causes of autism. Neuron, 77, 259–273.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this entry
Cite this entry
Chen, H. (2015). Autism. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6430-3_20-2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6430-3_20-2
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-6430-3
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences